Sociodemographic, clinical, and therapeutic characteristics of patients with Visceral Leishmaniasis in southwestern Maranhão, Brazil
DOI:
https://doi.org/10.21527/2176-7114.2025.50.15097Keywords:
Visceral Leishmaniasis, Epidemiology, Clinical Profile, Therapeutic Profile, Prevention and ControlAbstract
Introduction: Human Visceral Leishmaniasis (HVL) remains a significant public health issue in Brazil, with an estimated 400,000 cases and 20,000 to 40,000 deaths annually. Over the past three decades, the disease has rapidly expanded, primarily due to urbanization, resulting in a shift in its epidemiological profile toward urban centers. Despite this trend, regional data on the sociodemographic, clinical, and therapeutic characteristics of HVL cases remain limited, particularly in Maranhão. This study aimed to fill this gap by characterizing HVL cases in the southwestern region of the state. Methods: A descriptive, cross-sectional, and retrospective study was conducted using data from the Notifiable Diseases Information System (SINAN). HVL cases reported from 2009 to 2018 across sixteen municipalities within the macro-region of the 10th Health Regional Management Unit of Maranhão were analyzed. Results: A total of 623 HVL cases were recorded, with 95% classified as new cases. The incidence rate was 1.15 cases per 100,000 inhabitants over the ten-year period. Most cases involved male children from urban areas, revealing key sociodemographic patterns. Conclusions: The study confirmed the region's high endemicity and the predominance of new HVL cases. These findings highlight the need for enhanced surveillance efforts and underscore the clinical significance of early diagnosis.
References
1. Reis D, Albuquerque T, Soares M. As leishmanioses e o livro didático: como as doenças endêmicas são abordadas no ensino publico? Investigações em Ensino de Ciências; 2014; 19(1):91-8.
2. Dantas E. Avaliação in vitro da atividade leishmanicida do óleo essencial do caryocar brasiliense. Universidade vale do paraíba; 2015.
3. Dennis L. Kasper M, Stephen L. Hauser M, J. Larry Jameson, MD P, Anthony S. Fauci M, Dan L. Longo M, Joseph Loscalzo, MD P. Medicina interna de harrison. 18a. Porto Alegre, RS: AMGH Ed.; 2013.
4. Almeida L. Leishmanioses e derivados de furoxano e benzofuroxano: atividade biológica in vitro e in vivo e potenciais mecanismos de ação. Universidade Estadual Paulista Instituto de Química; 2017.
5. Alvarenga D, Escalda P, Costa A, Monreal M. Leishmaniose visceral: estudo retrospectivo de fatores associados à letalidade visceral. Rev Soc Bras Med Trop; 2010; 43(2):194-197.
6. Marcondes M, Rossi C. Leishmaniose visceral no brasil. 79913-110224-1-Pb. BRAZILIAN J Vet Res Anim Sci. 2013;50(341–352, 2013):341–52.
7. Rodrigues V, Cordeiro-Da-Silva A, Laforge M, Silvestre R, Estaquier J. Regulation of immunity during visceral leishmania infection. Parasites and Vectors. Parasites & Vectors; 2016;9(1):1–13.
8. Saúde EM. Brasil. Ministerio da Saúde. Secretaria de Vigilancia em Saúde. Departamento de Vigilancia Epidemiologica. Acidentes por Animais Peçonhnetos. In: Guia de vigilância em saúde. Ministério. Brasilia: Ministério da Saúde. Ms. 2014;1:719–38.
9. Alves W, Fonseca D. Leishmaniose visceral humana: estudo do perfil clínico-epidemiológico na região leste de minas gerais, brasil. J Heal Biol Sci. 2018;6(2):133.
10. Alves E, Costa C, Carvalho F, Cruz M, Werneck G. Risk profiles for leishmania infantum infection in brazil. Am J Trop Med Hyg. 2016;94(6):1276–81.
11. Werneck G. Expansão geográfica da leishmaniose visceral no brasil. Cad Saude Publica. 2010;26(4):644–5.
12. Ministério da saúde. Acidente por animais peçonhentos. Secretaria Estadual da Saúde RS/DVE/CEVS - Sistema de Informação de Agravos de Notificação - sinannet. 2016. 1 p.
13. Pimentel L. Leishmaniose visceral humana: indicação terapêutica e fatores associados à letalidade em uma região endêmica do nordeste brasileiro. Revista Saúde (Sta. Maria). 2022; 48.
14. Gil A. Como elaborar projetos de pesquisa. 4a. São Paulo: Atlas; 2002. 176 p.
15. Lucena R, Medeiros J. Caracterização epidemiológica da leishmaniose visceral humana no nordeste brasileiro entre 2010 e 2017. Journal of biology & pharmacy and agricultural management, out/dez 2018;14:285–98.
16. Rodrigues A, Melo A, Júnior A, Franco S, Rondon F, Bevilaqua C. Epidemiologia da leishmaniose visceral no município de fortaleza, ceará. Pesqui Vet Bras. 2017;37(10):1119–24.
17. Ortiz R, Anversa L. Epidemiologia da leishmaniose visceral em bauru, são paulo, no período de 2004 a 2012: um estudo descritivo. Epidemiol e Serviços Saúde. 2015;24(1):97–104.
18. Cardim M, Vieira C, Chiaravalloti-Neto F. Spatial and spatiotemporal occurrence of human visceral leishmaniasis in adamantina, state of são paulo, brazil. Rev Soc Bras Med Trop. 2015;48(6):716–23.
19. Bruhn F, Morais M, Bruhn N, Cardoso D, Ferreira F, Rocha C. Human visceral leishmaniasis: factors associated with deaths in belo horizonte, minas gerais state, brazil from 2006 to 2013. Epidemiology and Infection. 2018;146(5):565–70.
20. Silva M, Neto E, Saraiva D, Barreto W, Nascimento S, Moares J, Leite M, Costa J. Perfil clínico e epidemiológico da coinfecção leishmaniose visceral e vírus da imunodeficiência humana em estado endêmico. 54º Congresso da Sociedade Brasileira de Medicina Tropical, Pernambuco; 2018 Sep;67.
21. Dourado Z, Silva H, Silveira-Lacerda E, Garcia-Zapata M. Panorama histórico do diagnóstico laboratorial da leishmaniose visceral até o surgimento dos testes imunocromatográficos (rk39). Rev Patol Trop. 2007;36(3):205–14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Contexto & Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
